Regulatory T cell levels and cytokine production in active non‐infectious uveitis: in‐vitro effects of pharmacological treatment

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical and Experimental Immunology

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/cei.12479PMID 25354724PMCID PMC4337685
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pillars Article: Control of Regulatory T Cell Development by the Transcription Factor Foxp3. Science 2003. 299: 1057-1061.

  2017cited by this paper
• Adalimumab specifically induces CD3+ CD4+ CD25high Foxp3+ CD127− T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention study

  2012cited by this paper
• Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.

  2011cited by this paper
• Induction of regulatory T cells by infliximab in Behcet's disease.

  2011cited by this paper
• A look at autoimmunity and inflammation in the eye.

  2010cited by this paper
• IL‐10 and TGF‐β Immunoregulatory Cytokines rather than Natural Regulatory T Cells are Associated with the Resolution Phase of Vogt‐Koyanagi‐Harada (VKH) Syndrome

  2010cited by this paper
• FOXP3+ regulatory T cells in the human immune system

  2010cited by this paper
• Mechanisms of TNFα regulation in uveitis: focus on RNA-binding proteins.

  2010cited by this paper
• CD4+Foxp3+ T-regulatory cells in noninfectious uveitis.

  2009cited by this paper
• Steroid refractory CD4+ T cells in patients with sight-threatening uveitis.

  2009cited by this paper
• Anti tumour necrosis‐α therapy increases the number of FOXP3+ regulatory T cells in children affected by Crohn’s disease

  2008cited by this paper
• Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.

  2008cited by this paper
• CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases

  2007cited by this paper
• CD4+CD25+ regulatory T cells in patients with Behçet's disease.

  2006cited by this paper
• Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans

  2006cited by this paper
• The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells

  2006cited by this paper
• Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

  2005cited by this paper
• Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis.

  2005cited by this paper
• Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.

  2005cited by this paper
• Incidence and prevalence of uveitis in Northern California

  2004cited by this paper
• Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study.

  2004cited by this paper
• Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy

  2004cited by this paper
• Anti-TNFalpha therapy modulates the phenotype of peripheral blood CD4+ T cells in patients with posterior segment intraocular inflammation.

  2004cited by this paper
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

  2003cited by this paper
• Supporting Online Material

  2002cited by this paper
• Type 1 T regulatory cells

  2001cited by this paper
• Aqueous Humor and Serum Tumor Necrosis Factor-α in Clinical Uveitis

  2001cited by this paper
• Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

  2000cited by this paper
• IL-10 has a protective role in experimental autoimmune uveoretinitis.

  1998cited by this paper
• Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis.

  1998cited by this paper
• Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.

  1996cited by this paper
• The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis

  1994cited by this paper
• The natural history of uveitis

  1990cited by this paper
• Cyclosporin in the treatment of severe chronic idiopathic uveitis.

  1990cited by this paper
• International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease.

  1987cited by this paper

• Unravelling T‐cell dynamics and immune responses in initial and recurrent uveitis

  2024cites this paper
• Dysregulated Th17/Treg cell axis is correlated with local and systemic immune response in human intermediate uveitis.

  2024cites this paper
• Tregs in Autoimmune Uveitis.

  2021cites this paper
• Imbalance in PB IL-17-Secreting and Regulatory Cells in Pars Planitis Is Associated with Dysregulation of IFN-γ-Secreting Cells, Especially in Patients with Clinical Complications

  2020cites this paper
• Analysis of peripheral inflammatory T cell subsets and their effector function in patients with Birdshot Retinochoroiditis

  2020cites this paper
• Betamethasone induces potent immunosuppression and reduces HIV infection in a PBMC in vitro model

  2020cites this paper
• Regulatory T cells and IL-17A levels in noninfectious uveitis

  2020influential citation
• Guide to Immunopharmacology: a database to boost immunology education, research and therapy

  2020cites this paper
• Systemic Regulatory T Cells and IL-6 as Prognostic Factors for Anatomical Improvement of Uveitic Macular Edema

  2020cites this paper
• CD55 Is Essential for CD103+ Dendritic Cell Tolerogenic Responses that Protect against Autoimmunity.

  2019cites this paper
• Activation of the Notch signaling pathway disturbs the CD4+/CD8+, Th17/Treg balance in rats with experimental autoimmune uveitis

  2019cites this paper
• Association Between Noninfectious Uveitis and Psychological Stress

  2019cites this paper
• A multifaceted approach to improving management of sight-threatening non-infectious uveitis : patient perspectives and disease phenotyping for individualised patient therapy

  2018cites this paper
• Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT

  2018cites this paper
• High-Dimensional Profiling Reveals Heterogeneity of the Th17 Subset and Its Association With Systemic Immunomodulatory Treatment in Non-infectious Uveitis

  2018cites this paper
• Quantitative Determination of Volume Conductivity and Scatter Parameters to Predict Mortality of Patients in Intensive Care Units

  2018cites this paper
• Physio-pharmacological Investigations About the Anti-inflammatory and Antinociceptive Efficacy of (+)-Limonene Epoxide

  2017cites this paper
• Elevated Serum Immune Mediators and Subclinical Inflammation in HLA-A29-associated Birdshot Chorioretinopathy

  2016cites this paper
• Phenotypic changes of peripheral blood mononuclear cells upon corticosteroid treatment in idiopathic intermediate uveitis.

  2016cites this paper
• Anti-inflammatory effects of dexamethasone and meloxicam on Borrelia burgdorferi-induced inflammation in neuronal cultures of dorsal root ganglia and myelinating cells of the peripheral nervous system

  2015cites this paper
• Inhibition of Noninfectious Uveitis Using Intravenous Administration of Collagen II-Specific Type 1 Regulatory T Cells.

  2015cites this paper
• Clinicopathological Relevance of Volume , Conductivity and Scatter Parameters in Critically Ill Patients

  year unknowncites this paper